BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30015227)

  • 41. Predicting post-discharge venous thromboembolism and bleeding among medical patients: External validation of a novel risk score utilizing ubiquitous biomarkers.
    Hyder SN; Han HB; Ash S; Horne BD; Stevens SM; Woller SC; Barnes GD
    Thromb Res; 2023 Jul; 227():45-50. PubMed ID: 37235947
    [TBL] [Abstract][Full Text] [Related]  

  • 42. To prophylax or not, and how much and how long? Controversies in VTE prevention for medical inpatients, including COVID-19 inpatients.
    Spyropoulos AC
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):506-514. PubMed ID: 36485109
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trial.
    Khorana AA; Francis CW; Kuderer NM; Carrier M; Ortel TL; Wun T; Rubens D; Hobbs S; Iyer R; Peterson D; Baran A; Kaproth-Joslin K; Lyman GH
    Thromb Res; 2017 Mar; 151():89-95. PubMed ID: 28139259
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improvement of appropriate pharmacological prophylaxis in hospitalised cancer patients with a multiscreen e-alert system: a single-centre experience.
    Figueroa R; Alfonso A; López-Picazo J; Gil-Bazo I; García-Mouriz A; Hermida J; Páramo JA; Lecumberri R
    Clin Transl Oncol; 2019 Jun; 21(6):805-809. PubMed ID: 30446983
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Venous thromboembolism in hospitalized patients with active cancer.
    Piazza G; Rao AF; Nguyen TN; Seger AC; Hohlfelder B; Fanikos J; Goldhaber SZ
    Clin Appl Thromb Hemost; 2013 Sep; 19(5):469-75. PubMed ID: 23482721
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score.
    Barbar S; Noventa F; Rossetto V; Ferrari A; Brandolin B; Perlati M; De Bon E; Tormene D; Pagnan A; Prandoni P
    J Thromb Haemost; 2010 Nov; 8(11):2450-7. PubMed ID: 20738765
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Venous thromboembolism prophylaxis with anticoagulation in septic patients: a prospective cohort study.
    Zusman O; Paul M; Farbman L; Daitch V; Akayzen Y; Witberg G; Avni T; Gafter-Gvili A; Leibovici L
    QJM; 2015 Mar; 108(3):197-204. PubMed ID: 25190265
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting. The Recovery Study.
    Kahn SR; Springmann V; Schulman S; Martineau J; Stewart JA; Komari N; McLeod A; Strulovitch C; Blostein M; Faucher JP; Gamble G; Gordon W; Kagoma PK; Miron MJ; Laverdière D; Game M; Mills A
    Thromb Haemost; 2012 Sep; 108(3):493-8. PubMed ID: 22782073
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inpatient prophylaxis in cancer patients: where is the evidence?
    Patell R; Zwicker JI
    Thromb Res; 2020 Jul; 191 Suppl 1():S85-S90. PubMed ID: 32736785
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estimation of Acutely Ill Medical Patients at Venous Thromboembolism Risk Eligible for Extended Thromboprophylaxis Using APEX Criteria in US Hospitals.
    Martin AC; Huang W; Goldhaber SZ; Hull RD; Hernandez AF; Gibson CM; Anderson FA; Cohen AT
    Clin Appl Thromb Hemost; 2019; 25():1076029619880008. PubMed ID: 31588785
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Venous thromboembolism prophylaxis after total knee or hip replacement: treatment pattern and outcomes.
    Penning-van Beest FJ; Overbeek JA; Meijer WM; Woodruff K; Jackson J; van der Vis H; van der Linden P; Herings RM
    Pharmacoepidemiol Drug Saf; 2011 Sep; 20(9):972-8. PubMed ID: 21748826
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study.
    Kopolovic I; Lee AY; Wu C
    Ann Hematol; 2015 Feb; 94(2):329-36. PubMed ID: 25190031
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predicting risk of venous thromboembolism in hospitalized cancer patients: Utility of a risk assessment tool.
    Patell R; Rybicki L; McCrae KR; Khorana AA
    Am J Hematol; 2017 Jun; 92(6):501-507. PubMed ID: 28240823
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 55. One-year incidence of venous thromboembolism, bleeding, and death in patients with solid tumors newly initiating cancer treatment: Results from the Cancer-VTE Registry.
    Ohashi Y; Ikeda M; Kunitoh H; Sasako M; Okusaka T; Mukai H; Fujiwara K; Nakamura M; Oba MS; Kimura T; Ibusuki K; Takita A; Sakon M
    Thromb Res; 2022 May; 213():203-213. PubMed ID: 35282898
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incidence and predictors of venous thromboembolism in medically ill hospitalized elderly cancer patients: a prospective observational study.
    Lee JO; Lee JY; Chun EJ; Choi SI; Kim JW; Kim SH; Kim YJ; Lee KW; Kim JH; Lee JS; Bang SM
    Support Care Cancer; 2019 Jul; 27(7):2507-2515. PubMed ID: 30397900
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predicting recurrences or major bleeding in women with cancer and venous thromboembolism. Findings from the RIETE Registry.
    Trujillo-Santos J; Ruiz-Gamietea A; Luque JM; Samperiz AL; Garcia-Bragado F; Todoli JA; Monreal M;
    Thromb Res; 2009; 123 Suppl 2():S10-5. PubMed ID: 19217463
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prior thromboprophylaxis and outcome in patients experiencing acute venous thromboembolism after an acute medical illness.
    Merah A; Bertoletti L; Ginzarly M; Zeltser D; Barrón M; Cañas I; Villalta J; Bucherini E; Monreal M;
    Eur J Intern Med; 2016 May; 30():72-76. PubMed ID: 26975476
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk.
    Muriel A; Jiménez D; Aujesky D; Bertoletti L; Decousus H; Laporte S; Mismetti P; Muñoz FJ; Yusen R; Monreal M;
    J Am Coll Cardiol; 2014 Apr; 63(16):1675-83. PubMed ID: 24576432
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bleeding complications associated with anticoagulant therapy in patients with cancer.
    Trujillo-Santos J; Nieto JA; Ruíz-Gamietea A; López-Jiménez L; García-Bragado F; Quintavalla R; Monreal M;
    Thromb Res; 2010 Apr; 125 Suppl 2():S58-61. PubMed ID: 20434007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.